GUFICBIO.NS
Gufic Biosciences Limited$371.25
Jun 12, 2026
Market cap
$37.28B
52w range
—
P / E
—
EPS · FY 2026
$6.40
Volume
—
Revenue · FY 2026
$9.44B
Explain this page
Arphra AIPlain-English read on Gufic Biosciences Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$138.99
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →GUFICBIO.NS
371.25+22.93%H 392.95L 268.00MA50 301.73MA200 —Avg vol 83K
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Financial Services+1.42%
- Utilities+0.91%
- Energy+0.70%
- Industrials+0.26%
- Technology+0.18%
- Communication Services+0.17%
- Consumer Defensive+0.15%
- Real Estate-0.49%
- Healthcare-0.50%
- Consumer Cyclical-0.50%
- Basic Materials-0.82%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-1.40%
- Department Stores-5.35%
- Oil & Gas Energy+4.44%
- Electronic Gaming & Multimedia+3.70%
- Trucking-3.23%
- Copper-3.12%
- Medical - Equipment & Services+3.07%
- Luxury Goods+3.06%
- Software - Infrastructure+2.91%
- Steel-2.75%
- Regulated Water+2.54%
- Communication Equipment-2.42%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for GUFICBIO.NS.
Peers
No peer list available for GUFICBIO.NS.
Total assets
$13.42B
Total debt
$4.05B
Cash & equiv
$762.17M
Operating CF
$131.71M
Free cash flow
-$180.11M
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $9.44B | $1.21B | $642.15M | $6.40 | +6.80% |